BTAIVSVTGN• 3 Months (Normalized)
BTAI vs VTGN (BioXcel Therapeutics Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-97.5%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
+%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin VTGN LEADS
-97.5 pts
VTGN outperforming by 97.50 percentage points
BTAIVTGN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | BTAI Price | BTAI Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $0.04 | -97.50% | $- | - | |
| Sep 23, 2026 | $0.05 | -96.81% | $0.37 | +60.87% | -157.68% |
| Sep 22, 2026 | $0.04 | -96.84% | $0.25 | +8.70% | -105.54% |
| Sep 21, 2026 | $0.06 | -95.64% | $0.23 | +0.00% | -95.64% |
| Sep 18, 2026 | $0.06 | -95.89% | $0.24 | +4.35% | -100.24% |
| Sep 17, 2026 | $0.08 | -94.67% | $0.23 | +0.00% | -94.67% |
| Sep 16, 2026 | $0.07 | -95.26% | $0.23 | +0.00% | -95.26% |
| Sep 15, 2026 | $0.04 | -96.83% | $0.24 | +4.35% | -101.18% |
| Sep 14, 2026 | $0.05 | -96.80% | $0.24 | +5.74% | -102.54% |
| Sep 11, 2026 | $0.05 | -96.38% | $0.24 | +4.35% | -100.73% |
| Sep 10, 2026 | $0.05 | -96.45% | $0.24 | +4.35% | -100.80% |
| Sep 09, 2026 | $0.05 | -96.67% | $0.24 | +4.35% | -101.02% |
| Sep 08, 2026 | $0.04 | -96.95% | $0.24 | +4.35% | -101.30% |
| Sep 04, 2026 | $0.07 | -94.76% | $0.24 | +4.35% | -99.11% |
| Sep 03, 2026 | $0.12 | -91.63% | $0.25 | +8.70% | -100.33% |
Page 1 of 5